Implandata Ophthalmic Products raises €3.0M Series B round

The proceeds were used to complete the clinical program for CE marking, launch further studies in Germany and abroad (specifically the US), and establish a US subsidiary.

Source: https://www.biospace.com/article/releases/implandata-announces-closing-of-3m-series-b-round-establishment-of-fully-owned-usa-subsidiary-and-progress-in-clinical-program-/